A multiple candidate-gene approach was used to investigate not only candidate genes, but also candidate pathways involved in the regulation of blood pressure. We evaluated 307 single nucleotide polymorphisms (SNPs) in 307 genes and performed an association study between 758 cases and 726 controls. Genes were selected from among those encoding components of signal transduction pathways, including receptors, soluble carrier proteins, binding proteins, channels, enzymes, and G-proteins, that are potentially related to blood pressure regulation. In total, 38 SNPs were positively (p <0.05) associated with hypertension. Replication of the findings and possible polygenic interaction was evaluated in five G-protein-related positive genes (GNI2, GNA14, RGS2, RGS19, RGS20) in a large cohort population (total n =9,700, 3,305 hypertensives and 3,827 normotensive controls). In RGS20 and GNA14, dominant models for the minor allele were significantly associated with hypertension. Multiple dimension reduction (MDR) analysis revealed the presence of gene-gene interaction between GNA14 and RGS20. The MDR-proved combination of two genotypes showed a significant association with hypertension ( 2 = 9.93, p = 0.0016) with an odds ratio of the high-risk genotype of 1.168 (95% confidence interval [CI] [1.061-1.287]). After correction for all possible confounding parameters, the MDR-proved high-risk genotype was still a risk for hypertension ( p = 0.0052). Furthermore, the highrisk genotype was associated with a significantly higher systolic blood pressure (133.not only hypertension-susceptibility genes but also hypertension-susceptibility pathways in which related genes may synergistically collaborate through gene-gene interactions to predispose to hypertension. 2008; 31: 203-212) 
Introduction
Hypertension is one of the most common complex genetic disorders affecting a large population, with a genetic heritability ranging from 15% to 35% ( 1 -5 ) . Like other multifactorial human traits, hypertension is caused by the interaction of multiple risk genes and environmental risk factors ( 1 -5 ) .
Vigorous efforts have been made to identify genes for hypertension. The candidate gene approach is a cornerstone for identifying the hypertension-susceptibility gene(s). Several candidate genes have been selected on the basis of known biochemical or physiologic components related to blood pressure regulation. However, the results of these studies have not been consistent, and the positive findings have rarely been replicated. Several underlying causes have been postulated to explain the failure of these studies to reproduce the data on candidate gene(s), including the heterogeneity of cases and controls, population stratification, and gene-gene and geneenvironment interactions ( 1 -5 ) . In addition, it has been demonstrated that genetic interactions at multiple loci rather than a variant of a single gene underlie the genetic basis of hypertension ( 1 -5 ) .
Hypertension is polygenic ( 6 -8 ) , with alleles at many different loci being suggested to contribute to the ultimate disease trait, and specific combinations of causative alleles may differ between individuals ( 6 -9 ). Although several candidate genes have been associated with the development of hypertension, the mechanisms and genetic network underlying this disease remain unknown ( 3 ) . It has been persuasively argued that the gene being assessed increases susceptibility for the disease, but its effect is not sufficient to cause the disease ( 3 ) .
Accordingly, the strategy for the candidate gene approach needs to be changed to detect polygenetic factors with weak effects. There has been a trend towards the simultaneous evaluation of several polymorphisms in separate genes ( 4 , 10 , 11 ) . Combinations of polymorphisms at several of these loci could steadily increase the odds ratio for predicting hypertension or a hypertensive intermediate phenotype ( 12 -16 ) . However, the above-referenced studies were directed at genes for which there was a published association with hypertension. To search for multiple novel genes interacting with each other, it would be rational to find a specific pathway in which the genes are involved. Dominiczak et al . ( 17 ) referred to "pathwayomics," meaning a cardiovascular continuum leading from the investigation of interrogation of multiple single nucleotide polymorphisms (SNPs) in genes for a specific pathway. No study has ever evaluated susceptibility pathways in which multiple genes interact with each other to cause hypertension.
In the present study, we evaluated multiple genes to identify not only candidate genes but also candidate pathways in which multiple genes are synergistically involved in the regulation of blood pressure. The study was performed one of the Millennium Genome Project. In 2000, a series of national cooperative projects were begun under the auspices of the Prime Minister's Millennium Project ( 18 ) . The projects focus on bold technological innovations in three areas: informatization, the aging society and the environment. The identification of genetic variations linked to the development of hypertension is one of the leading missions of the Millennium Project. Four other diseases-diabetes mellitus, cancer, asthma, and Alzheimer's disease-have also been chosen as targets for gene search.
In the present study, we evaluated 307 SNPs in 307 genes, and performed an association study between 758 cases and 726 controls. Genes were selected from those related to signal transduction pathways that included receptors, soluble carrier proteins, binding proteins, channels, enzymes, and G-proteins, and that were possibly related to blood pressure regulation. A replication study of positive G-protein-related SNPs including possible gene-gene interactions was further performed in a larger, independent general population.
Methods

Subjects
Case-Control Study
The present study was performed as part of the Millennium Genome Project for Hypertension under the auspices of the National Millennium Project in Japan. Four centers throughout Japan, located in Asahikawa, Tokyo, Osaka, and Hiroshima, participated in the case-control study. Cases and controls were recruited at each center, using the same criteria.
Hypertensive subjects ( n = 758) had a previous diagnosis of hypertension at between 30 and 59 years of age and were being treated with antihypertensive medication or had a systolic blood pressure (SBP) ≥ 160 mmHg and/or diastolic blood pressure (DBP) ≥ 90 mmHg. They had a family history of hypertension in their parents and/or siblings. They were not obese (body mass index [BMI] < 25 kg/m 2 ). Normotensive controls (n= 726) aged more than 45 years were recruited from the same regions. They had never been treated with antihypertensive medication and their SBP was < 120 mmHg and DBP < 80 mmHg. They had no family history of hypertension. Table 1 summarizes the background characteristics of the cases and controls.
Replication Study
Replication of positive findings including gene-gene interactions was evaluated in a large, independent general population recruited from five cohorts throughout Japan (Ohasama, Yokohama, Shigaraki, Ehime 1 and Ehime 2) (19) (20) (21) (22) . Subjects aged ≥ 30 years were enrolled in the analysis. Measurement of blood pressure, an anthropometric and biochemical parameters was performed during a medical checkup. Table 2 summarizes the clinical characteristics of the population. In this population sample, hypertension was defined as an SBP ≥ 160 mmHg and/or DBP ≥ 90 mmHg, or current use of antihypertensive medication. Normotension was defined as SBP < 140 mmHg and DBP < 90 mmHg and no current use of antihypertensive medication. Among the total 9,700 subjects, 3,305 were defined as hypertensives and 3,827 were classified as normotensive controls.
All of the participants in the study were native Japanese. All participants received a full explanation of the purpose of the study, and written informed consent for the procedures was obtained. The entire protocol followed the guidelines for genomic research of the Japanese government and was approved by the ethical committees of all institutes participating in the project.
SNP Selection
Three hundred and seven SNPs of the following types were selected. 1) SNPs in genes encoding the components of signal transduction systems, including enzymes, channels, receptors, solute carriers, G-proteins, and binding proteins, that are potentially related to blood pressure regulation. SNPs in other genes of particular interest, such as collagens, growth factors, adhesion molecules, and hormones, were also evaluated. 2) From among these 307 SNPs, we selected one SNP from one gene, preferably in the promoter region or exons with the highest minor allele frequency in the Japanese population, was selected based on information published in the JSNP website (23) (http://snp.ims.u-tokyo.ac.jp/index.html). 3) To find novel susceptible genes, unpublished SNPs were selectively studied. All SNPs examined in the present study are listed in the Online Data Supplement 1 (it is up-loaded to J-STAGE).
Genotyping
DNA was extracted from white blood cells by the standard method, at each institute. The whole genome was amplified by degenerated oligonucleotide primer (DOP)-polymerase chain reaction (PCR) in the Core Laboratory of the Department of Geriatric Medicine, Ehime University. DOP-PCR was performed according to a previous report, with slight modifications (24, 25) . In brief, 10 ng genomic DNA was used as a template in a 100-μL reaction mixture containing 5 U polymerase (TaKaRa LA Taq; Takara Biomedicals, Tokyo, Japan), 2.5 mmol/L MgCl2, 400 μmol/L dNTP, and 4 μmol/L DOP primer (5′-CCGACTCGAGNNNNNNATGTGG-3′; Sigma Genosys Japan, Ishikari, Japan). The amplification conditions consisted of an initial incubation at 93°C for 1 min; followed by 8 cycles of 93°C for 1 min, 30°C for 1 min, and 72°C for 3 min; followed by 28 cycles of 93°C for 1 min, 60°C for 1 min, and 72°C for 3 min. The initial denaturation for 8 min at 96°C was omitted. The quality of amplified DNA obtained by DOP-PCR was checked in all samples.
Genotyping for the case-control study was performed in the Human SNP Typing Center of Tokyo University (Department of Human Genetics) using automated fluorescence correlation spectroscopy (26) , and in the Core Lab of the Department of Geriatric Medicine, Ehime University, by the TaqMan PCR method.
Genotyping for the replication population study was performed at Ehime University using a TaqMan SNP genotyping assay system. The structures of primers and probes are listed in the Online Data Supplement 2 (it is up-loaded to J-STAGE).
Statistical Analysis
For comparison of the baseline characteristics between cases and controls, Student's unpaired t-test for continuous data and χ 2 test for categorical data were used. Differences in genotype and allele frequency between cases and controls were evaluated by χ 2 test. In the present study, both recessive and dominant models for the minor allele were considered.
Gene-gene interaction was evaluated by the multiple dimension reduction (MDR) method developed by Ritchie et al. (27) . Genes were evaluated with a specific model, either dominant or recessive. This method included a combined cross-validation and permutation-testing procedure that mini- mizes false-positive results by multiple examinations of the data. Cross-validation divides the data into a training set and a testing set. In 10-fold cross-validation, the data are divided into 10 equal parts, and the model is developed based on 9/10 of the data (training set) and then tested on the remaining 1/10 of the data (testing set). This is repeated for each possible training set, and the resulting 10 prediction errors are averaged (27) . The genotype combination obtained by the MDR method was then re-evaluated with an χ 2 test in the total population. Furthermore, differences in SBP and DBP as quantitative traits between MDR-defined genotypes were evaluated by ANOVA. Values are expressed as the means±SD. Values of p< 0.05 were defined as statistically significant.
Results
Case-Control Study
Sixty-five percent of hypertensive cases were receiving antihypertensive medication. There were no region-specific differences in the parameters examined.
Systemic Multiple Candidate Gene Analysis
Of the 307 SNPs, 13 showed p values less than 0.05 in genotype frequency, 23 showed a significantly different allele frequency between cases and controls, and 32 showed significant associations with hypertension in either a dominant or recessive model for the minor allele. In total, 38 SNPs were found to be positively associated with hypertension ( Table 3 ).
In the subcategorized analysis, the positive rate was high in genes related to G-proteins and genes of solute carriers ( Table  4 ). The positive rate of SNPs in genes encoding the Gα-subunit or RGS (5/12), which could possibly interact with each other, was significantly higher than those in other classes of genes (5/12 vs. 33/295, χ 2 = 6.2, p= 0.013).
Replication in a Large Cohort Population
Replication of the findings of the case-control study and possible polygenic interaction in the susceptible pathway was evaluated in G-protein-related genes in a large cohort population. Table 2 summarizes the clinical characteristics of the cohort population sample, from which 3,305 hypertensive subjects and 3,827 normotensive controls were recruited. Allele and genotype frequencies of the five G-protein-related SNPs in the cohort population are summarized in Table 5 . The genotypes of GNA14 showed significant associations with hypertension. In RGS20 and GNA14, dominant models for the minor allele were significantly associated with hypertension. Accordingly, the gene-gene interaction of G-protein-related genes was evaluated in GNA14 and RGS20.
Gene-Gene Interaction
MDR analysis showed that the combination of two SNPs, GNA14 and RGS20, had a testing accuracy of 0.526 and cross-validation consistency of 10/10 (p= 0.025), by sign test ( Table 6 ). An empirical permutation test with 1,000 replications showed that the combination was statistically significant (p= 0.01). Therefore, we concluded the presence of a genegene interaction between GNA14 and RGS20. The MDR-proved combination of GNA14 and RGS20 was further verified in the cohort population ( Table 7 ). The com-bination of the genotypes of GNA14 and RGS20 showed significant association with hypertension in the population (χ 2 = 9.93, p= 0.0016). The odds ratio of the risk genotype (GNA14: CC +TC and RGS20: CC +CG) to the non-risk genotypes defined by the MDR method was 1.168 (95% confidence interval [CI] [1.061-1.287], p= 0.0016). Since the prevalence of hypertensives and normotensives was signifi- The blood pressure levels of the combined genotype were further evaluated in the total population of the cohort (n= 9,700) ( Table 8 ). The risk genotype was associated with a significantly higher SBP and DBP. Even after correction for other confounding parameters, including region, sex, age, BMI, use of antihypertensive medication, total cholesterol, HDL cholesterol, triglycerides and fasting glucose, DBP in the high-risk genotype was still significantly higher compared with that in the non-risk genotype (p= 0.0294).
Discussion
Hypertension is a polygenic disease in which individual genes contribute only a very weak genetic effect (1) (2) (3) (4) (5) . Furthermore, epigenetic effects could play pivotal roles. Accordingly, a conventional candidate gene approach may limit the possibility of detecting the susceptible genes for hypertension, since the effect of a single gene might not always be detected in different populations. Several studies have evaluated multiple genes as candidate hypertension genes and evaluated gene-gene interactions among candidate genes (10) (11) (12) (13) (14) (15) (16) . However, many of these genes evaluated so far were already reported as positive genes in a previous candidate gene study. The strategy we took in the present study was to search for not only susceptibility genes, but also susceptibility pathways for hypertension using a candidate gene approach. The results raised the possibility that many susceptibility genes play an indirect role and exist in numerous pathways involved in blood pressure regulation.
The candidate genes evaluated thus far include genes within the renin-angiotensin system, α-adrenergic and βadrenergic receptors, and growth factors, as well as genes encoding enzymes and peptides involved in endothelial function and vasoactivity (17) . In the present study, we chose genes in signal transduction pathways possibly related to blood pressure regulation. The results revealed that none of the genes showed a high odds ratio or small p value.
Candidate SNPs were selected from among those in the gene of interest with the highest minor allele frequencies based on the JSNP data (23) . The rationale behind this strategy is the common-disease/common-variant (CD/CV) hypothesis (28, 29) . Although several authors have argued that the CD/CV hypothesis has not been sufficiently validated (5, 30, 31) , detection of susceptibility genes with low frequency is beyond the power of a conventional case-control approach, and at least this approach has the necessary statistical power to detect an association.
We demonstrated that positive SNPs were more common in genes related to G-proteins. We found that SNPs in genes that encoded ATPase, channels and solute carrier proteins also showed a higher positive rate. Among the positive pathways, replication of G-protein-related genes, including gene-gene interaction, was evaluated. Two of five positive G-protein- Hcy, homocysteine; RGS, regulator of G-protein signaling; VEGF, vascular endothelial growth factor; FGF, fibroblast growth factor; IGF, insulin-like growth factor; IL1, interleukin 1; TNF, tumor necrosis factor; HLA, human leukocyte antigen.
related SNPs in the case-control study, GNA14 and RGS20, were also positively associated with hypertension in a replicated study in a large general population. Furthermore, possible gene-gene interaction was found between the two genes. Heterotrimeric G-proteins are central components of the primary mechanism to receive, interpret and respond to a wide range of structurally and chemically diverse extracellular stimuli (32, 33) . Agonist binding of G-protein-coupled receptors (PCRs) promotes G-protein activation. This activation is achieved by catalyzing the GDP-GTP exchange on the α-subunit. A conformational change in the GTP-bound αsubunit leads to dissociation of Gα from the βand γ-subunits. GTP-bound Gα-subunits and dissociated βγ-dimers regulate downstream effectors. These signaling events are terminated as a consequence of intrinsic GTPase activity of the Gα-subunit, which hydrolyzes bound GTP to GDP, resulting in reassociation of the G-protein heterotrimer (34) . The intrinsic GTPase activity of α-subunits is generally insufficient to correlate with the physiological rate of G-protein inactivation, but this activity can be accelerated by the presence of GTPase-activating proteins (GAPs), such as regulator of Gprotein-signaling (RGS) proteins (35) .
Although the present study showed there is a statistically significant gene-gene interaction between GNA14 and RGS20, the details of this interaction remain to be clarified. Although GNA14 is much less promiscuous than GNA15 or GNA16, it has the ability to interact with several selective Gicoupled receptors, such as α2-adrenergic, δ-opioid, ORL1 and SSTR3, to increase IP formation (36) . On the other hand, it has also been shown that transfected RGSZ1 blocked mitogen-activated protein kinase activity induced by an α2-adrenergic receptor agonist (37) . Taken together, these findings may indicate that GNA14 and RGS20 can interact through α2-adrenergic receptor. However, how the gene-gene interaction observed in the present study is functionally related to hypertension needs to be biologically determined.
In the present study, we used the MDR method to evaluate gene-gene interactions. The MDR method has been widely used for statistical mining of gene-gene and gene-environmental interactions (38, 39) . The dimensionality reduction approach seeks to identify combinations among multilocus genotypes that are associated with high risk of disease as well as combinations associated with low risk. Thus, MDR defines a single variable that incorporates information from several loci and/or environmental factors that can be divided into high-risk and low-risk combinations. This new variable can be evaluated for its ability to classify and predict disease risk status using cross-validation and permutation testing (27) . The findings obtained by the MDR method need to be further confirmed not only in a separate population, but also by functional analysis.
The present study has several important limitations, including the threshold that was used to identify a positive gene (40, 41) . We used the statistical threshold of a p value less than 0.05. However, since we evaluated more than 300 genes at the same time, it would be have been more appropriate to use the probability threshold of Bonferroni correction-i.e., p< 0.00016 (= 0.05/307) instead of 0.05. With this strict definition, there were no significant SNPs related to hypertension in the case-control study. However, since we used the present findings to further extend the research, it could be appropriate to adopt a weaker criterion to pick up positive SNPs. The statistics should be used as a guide to make decisions on whether further study would be necessary with the given probability (40) .
To determine whether a finding with an observed p-value is noteworthy for publication, it has also been postulated that false-positive report probability should be evaluated based on the prior probability in the case-control association study with candidate genes (42, 43) . False-positive report probability has been shown to be influenced by statistical power, sample size, odds ratio, minor allele frequency, and p value of the association. In the present replication study, we had set moderate to low prior probability, i.e., 0.1-0.01, since associations between genes and hypertension were already observed in the case-control study. The risk genotype obtained by the MDR method showed a false-positive report probability ranging from 0.02-0.2 with moderate to low prior probability, indicating that the observed positive findings are worthy of reporting (43) .
The CD/CV hypothesis and common disease rare variant hypothesis have been debated (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) (41) . In the present study, candidate SNPs were selected on the basis of the common variant hypothesis. A multiple candidate gene approach for directing "pathwayomics" revealed that the effect of each SNP was small. Although exact replication of the original findings was not observed in the general population study, we did detect a gene-gene interaction which could have furthered increased the power of the effect of genes not only on hyper-tension but also on blood pressure variability. Again, however, the odds ratio was not high. Accordingly, the present findings were not consistent with the CD/CV hypothesis, since this hypothesis requires that the common variant should have at least a moderate effect on the phenotype (28) . However, we could not eliminate the possibility that the common variants have only small effects and hypertension consists of numerous combinations of common variants with small effects.
In a study evaluating the effects of inbreeding on blood pressure as a quantitative trait within Croatian island isolates, a model of the distribution of locus effects suggested that the 8-16 quantitative trait loci (QTLs) of largest effect together account for a maximum of 25% of the dominance variation, while the remaining 75% of the variation is mediated by QTLs of very small effect, unlikely to be detectable using current technologies and sample sizes (44) . The small but significant and independent effect on blood pressure variability observed in the high-risk genotype in the present study may support their findings. There is a possibility that numerous common genes with a small effect on blood pressure, either alone or in combination with other genes in the pathways, are responsible for a major part of blood pressure variation. The present findings may provide evidence that a common variant with a small effect, actually too small to influence blood pressure by itself, could be related to blood pressure variation and hypertension through combination with other common variants with a small effect allele in the same pathway. Since the effects (odds ratios) of the genes are very small, they could not be detected if their allele frequencies are low. These findings may underlie the failure of replication of candidate gene findings.
In the first case-control studies, 10 of 38 positive SNPs were found to deviate from the Hardy-Weinberg equilibrium (HWE). It has been shown that several underlying mechanisms may cause the violation of HWE (45) . However, the first study was a screening study to pick up the possible posi- tive SNPs, and all positive SNPs are scheduled to be genotyped in a large general population to reconfirm the findings, as five G-protein related SNPs were genotyped in the second population in the present study. Accordingly, in the present study, all results were present without any correction based on HWE.
In summary, the findings of the present study indicate that a systemic multiple candidate gene approach can be used to identify not only susceptibility genes but also susceptibility pathways in which related genes may synergistically collaborate through gene-gene interactions to predispose to hypertension. Our findings suggest that the CD/CV hypothesis can be challenged with numerous combinations of common variants with small effects.
